National Research Co. (NASDAQ:NRC) Shares Bought by BNP Paribas Financial Markets

BNP Paribas Financial Markets lifted its stake in shares of National Research Co. (NASDAQ:NRCFree Report) by 22.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,479 shares of the company’s stock after acquiring an additional 2,095 shares during the period. BNP Paribas Financial Markets’ holdings in National Research were worth $454,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in NRC. iA Global Asset Management Inc. acquired a new stake in shares of National Research during the third quarter valued at $11,124,000. Comerica Bank acquired a new stake in shares of National Research during the third quarter valued at $6,939,000. Skandinaviska Enskilda Banken AB publ boosted its stake in National Research by 114.3% in the 3rd quarter. Skandinaviska Enskilda Banken AB publ now owns 21,000 shares of the company’s stock worth $932,000 after buying an additional 11,200 shares during the last quarter. Vanguard Group Inc. boosted its stake in National Research by 1.1% in the 3rd quarter. Vanguard Group Inc. now owns 980,693 shares of the company’s stock worth $43,513,000 after buying an additional 10,454 shares during the last quarter. Finally, Kestra Private Wealth Services LLC acquired a new stake in National Research in the 3rd quarter worth about $409,000. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Stock Down 0.7 %

Shares of NASDAQ:NRC opened at $28.08 on Monday. The stock’s 50-day moving average price is $33.78 and its two-hundred day moving average price is $37.80. The company has a current ratio of 0.41, a quick ratio of 0.41 and a debt-to-equity ratio of 0.75. National Research Co. has a 12-month low of $27.45 and a 12-month high of $47.25. The firm has a market cap of $670.55 million, a price-to-earnings ratio of 22.65 and a beta of 0.45.

National Research (NASDAQ:NRCGet Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.27 earnings per share (EPS) for the quarter. National Research had a return on equity of 54.83% and a net margin of 20.60%. The firm had revenue of $35.31 million for the quarter.

National Research Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Friday, June 28th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.71%. The ex-dividend date is Friday, June 28th. National Research’s payout ratio is 38.71%.

About National Research

(Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Featured Stories

Institutional Ownership by Quarter for National Research (NASDAQ:NRC)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.